Bruno Gran - Concepedia

Author

Bruno Gran

University of Nottingham ORCID

Also Known As

B GRAN, B Gran, B. Gran, BENJAMIN GRAN, Bruno Gran, Gran, B, J. T Gran, B. Y Nordvåg, B Storesund, Marie Falahee

179

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

University of Nottingham Thomas Jefferson University National Institutes of Health National Institute of Neurological Disorders and Stroke University of Pennsylvania

About

Bruno Gran is an author at University of Nottingham specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	39	4.4K
2	Allergy	11	11	1.2K
3	Health Sciences	2	2	879
4	Public Health	2	2	68
5	Social Sciences	2	2	232

Bruno Gran

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand Bibiana Bielekova, Bonnie L. Goodwin, Nancy Richert, Nature Medicine Neurodegenerative DiseasesEncephalitogenic PotentialNeurobiology Of DiseaseNeurological DisorderMedicine	2000	819
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells Denise Fitzgerald, Guang‐Xian Zhang, Mohamed El Behi, Nature Immunology ImmunologyImmune RegulationInterleukin 27–StimulatedCd4 T Cell ResponsesT Cells	2007	527
IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination Bruno Gran, Guang‐Xian Zhang, Shuo Yu, The Journal of Immunology	2002	395
IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis Yaping Yan, Guang-Xian Zhang, Bruno Gran, The Journal of Immunology	2010	347
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, The Lancet Neurology Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology	2018	327
Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis Denise Fitzgerald, Bogoljub Ćirić, Tarik Touil, The Journal of Immunology Effector PhaseT-regulatory CellImmunologyImmune RegulationImmunologic Mechanism	2007	304
Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-β2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System Guang‐Xian Zhang, Bruno Gran, Shuo Yu, The Journal of Immunology Inflammatory DemyelinationAbstract Il-12ImmunodeficienciesImmunologyImmune Regulation	2003	302
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease Bernhard Hemmer, Bruno Gran, Yingdong Zhao, Nature Medicine Candidate T-cell EpitopesAllergyAutoimmune DiseaseImmunodeficienciesPathogenesis	1999	214
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells Felix J. Hartmann, Mohsen Khademi, Jehan Aram, Nature Communications InflammationCytokineImmunogeneticsAutoimmune DiseaseImmune Cell Development	2014	166
EAE: imperfect but useful models of multiple sclerosis Bert A. ‘t Hart, Bruno Gran, Robert Weissert Trends in Molecular Medicine Neurobiology Of DiseaseNeurological DisorderMedicineNeuroimagingNeurology	2011	163

Page 1